Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 43: 1188-1195, 1997;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (21)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takada, K.
Right arrow Articles by Ohkawa, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takada, K.
Right arrow Articles by Ohkawa, K.
Related Collections
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 1997;43:1188-1195.)
© 1997 American Association for Clinical Chemistry, Inc.

Articles

Serum concentrations of free ubiquitin and multiubiquitin chains

Koji Takada1,a, Hidekazu Nasu4, Nozomu Hibi4, Yutaka Tsukada4, Toshiaki Shibasaki2, Kiyotaka Fujise3, Masahiro Fujimuro5, Hitoshi Sawada5, Hideyoshi Yokosawa5 and Kiyoshi Ohkawa1

1 Department of Biochemistry (I),
2 Department of Internal Medicine (II), and
3 Department of Internal Medicine (Kashiwa Hospital), Jikei University School of Medicine, Minato-ku, Tokyo 105, Japan.

4 Department of Research Laboratory, SRL, Inc., Komiya-cho, Hachioji-shi, Tokyo 192, Japan.

5 Department of Biochemistry, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo 060, Japan.
a Author for correspondence. Fax 81-3-3435-1922;

Ubiquitin, which can conjugate with cellular proteins, is classified into two forms: free ubiquitin and multiubiquitin chains. The latter is active as a signal for degradation of the targeted proteins. We found both forms in human serum and, using two immunoassays, quantitated them in sera from healthy subjects and patients with some diseases. Because of putative leakage of erythrocyte ubiquitin, hemolytic serum and serum obtained after long incubation (>1–2 h) of blood at room temperature were excluded. Serum concentrations of multiubiquitin chains and free ubiquitin were substantially higher in rheumatoid arthritis and hemodialysis patients, respectively, than healthy subjects. Additionally, in acute viral hepatitis, serum multiubiquitin chain concentrations were increased in the acute phase, decreased in the recovery phase, and correlated with alanine and aspartate aminotransferase activities (r = 0.676 and 0.610, P <0.0001 and <0.001, respectively). Therefore, serum ubiquitin may have prognostic value.


Key Words: indexing terms: radioimmunoassay • enzyme-linked immunosorbent assay • hemolysis • hemodialysis • rheumatoid arthritis • acute viral hepatitis




The following articles in journals at HighWire Press have cited this article:


Home page
 BloodHome page
M. Majetschak, U. Krehmeier, M. Bardenheuer, C. Denz, M. Quintel, G. Voggenreiter, and U. Obertacke
Extracellular ubiquitin inhibits the TNF-alpha response to endotoxin in peripheral blood mononuclear cells and regulates endotoxin hyporesponsiveness in critical illness
Blood, March 1, 2003; 101(5): 1882 - 1890.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
E. Akarsu, I. Pirim, I. Çapoglu, O. Deniz, G. Akçay, and N. Ünüvar
Relationship Between Electroneurographic Changes and Serum Ubiquitin Levels in Patients With Type 2 Diabetes
Diabetes Care, January 1, 2001; 24(1): 100 - 103.
[Abstract] [Full Text]

Home page
 BloodHome page
H. Daino, I. Matsumura, K. Takada, J. Odajima, H. Tanaka, S. Ueda, H. Shibayama, H. Ikeda, M. Hibi, T. Machii, et al.
Induction of apoptosis by extracellular ubiquitin in human hematopoietic cells: possible involvement of STAT3 degradation by proteasome pathway in interleukin 6-dependent hematopoietic cells
Blood, April 15, 2000; 95(8): 2577 - 2585.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Association for Clinical Chemistry.